Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents. 2013

K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
Fluoroorganic Division, Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India.

A series of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives 5, 6 and 7 were prepared starting from 6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-3-amine 3 via selective N-alkylation, followed by reaction with different primary aliphatic amines, cyclic secondary amines or l-amino acids under different set of conditions. All the synthesized compounds 5, 6 and 7 were screened for anticancer activity against four cancer cell lines such as A549-Lung cancer (CCL-185), MCF7-Breast cancer (HTB-22), DU145-Prostate cancer (HTB-81) and HeLa-Cervical cancer (CCL-2). The compounds 5i and 6e are found to have promising bioactivity at micro molar concentration.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D054879 Halogenation Covalent attachment of HALOGENS to other compounds. Bromination,Chlorination,Fluorination,Iodination,Iodation

Related Publications

K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
August 2016, Bioorganic chemistry,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
September 2016, Bioorganic & medicinal chemistry letters,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
August 2018, Molecules (Basel, Switzerland),
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
August 2019, Bioorganic chemistry,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
January 2023, RSC medicinal chemistry,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
July 2021, Molecules (Basel, Switzerland),
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
September 2021, Molecules (Basel, Switzerland),
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
November 2009, European journal of medicinal chemistry,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
May 1989, Journal of medicinal chemistry,
K Chavva, and S Pillalamarri, and V Banda, and S Gautham, and J Gaddamedi, and P Yedla, and C G Kumar, and N Banda
January 2000, Bollettino chimico farmaceutico,
Copied contents to your clipboard!